Acetylation of Stat1 modulates NF-κB activity
Acetylation of Stat1 modulates NF-κB activity
复制标题
DOI:
10.1101/gad.364306
复制
发表时间:
2006-02-15
影响因子:
10.5
通讯作者:
Heinzel, T
中科院分区:
文献类型:
--
作者:
Krämer, OH;Baus, D;Heinzel, T
Acetylation of signaling molecules can lead to apoptosis or differentiation of carcinoma cells. The molecular mechanisms underlying these processes and the biological role of enzymes mediating the transfer or removal of an acetyl-group are currently under intense investigation. Our study shows that Stat1 is an acetylated protein. Stat1 acetylation depends on the balance between Stat1-associated histone deacetylases (HDACs) and histone acetyltransferases (HATs) such as CBP. Remarkably both inhibitors of HDACs and the cytokine interferon alpha alter this equilibrium and induce Stat1 acetylation. The analysis of Statl mutants reveals Lys 410 and Lys 413 as acetylation sites. Experiments with Statl mutants mimicking either constitutively acetylated or nonacetylated states show that only acetylated Stat1l is able to interact with NF-kappa B p65. As a consequence, p65 DNA binding, nuclear localization, and expression of anti-apoptotic NF-kappa B target genes decrease. These findings show how the acetylation of Statl regulates NF-kappa B activity and thus ultimately apoptosis.